tiprankstipranks
Advertisement
Advertisement

GB:FARN Stock Latest News

Faron raises EUR 40.1 million in rights issue to advance cancer drug bexmarilimab
Company AnnouncementsFaron raises EUR 40.1 million in rights issue to advance cancer drug bexmarilimab
10h ago
Faron raises €40 million in oversubscribed rights issue to drive bexmarilimab trials
PremiumCompany Announcements
Faron raises €40 million in oversubscribed rights issue to drive bexmarilimab trials
2d ago
Faron Chair Buys Shares in Rights Issue to Back Cancer Immunotherapy Drive
PremiumCompany Announcements
Faron Chair Buys Shares in Rights Issue to Back Cancer Immunotherapy Drive
10d ago
Faron bolsters late-stage push with new CTO for lead cancer immunotherapy
PremiumCompany Announcements
Faron bolsters late-stage push with new CTO for lead cancer immunotherapy
15d ago
Buy Rating Reiterated on Faron: De-Risked Bexmarilimab Strategy in High-Risk MDS and Upside from Solid Tumor Expansion
PremiumRatings
Buy Rating Reiterated on Faron: De-Risked Bexmarilimab Strategy in High-Risk MDS and Upside from Solid Tumor Expansion
22d ago
Faron CEO Boosts Stake in Rights Issue, Underscoring Confidence in Cancer Immunotherapy Pipeline
PremiumCompany AnnouncementsFaron CEO Boosts Stake in Rights Issue, Underscoring Confidence in Cancer Immunotherapy Pipeline
22d ago
Faron Senior Advisor Boosts Stake as Cancer Immunotherapy Trials Advance
Premium
Company Announcements
Faron Senior Advisor Boosts Stake as Cancer Immunotherapy Trials Advance
22d ago
Faron General Counsel Ups Stake in Rights Issue, Signaling Confidence in Immunotherapy Pipeline
Premium
Company Announcements
Faron General Counsel Ups Stake in Rights Issue, Signaling Confidence in Immunotherapy Pipeline
22d ago
Faron wins regulator nod for €40m rights issue to fund immunotherapy pipeline
PremiumCompany Announcements
Faron wins regulator nod for €40m rights issue to fund immunotherapy pipeline
29d ago
Faron launches fully covered EUR 40m rights issue to fund cancer drug trials and extend cash runway
PremiumCompany Announcements
Faron launches fully covered EUR 40m rights issue to fund cancer drug trials and extend cash runway
1M ago
Faron Reschedules 2026 AGM While Keeping Half-Year Report Date Unchanged
PremiumCompany Announcements
Faron Reschedules 2026 AGM While Keeping Half-Year Report Date Unchanged
1M ago
Faron Pharmaceuticals Corrects 2025 Annual Report to Add Missing Auditor’s Report
PremiumCompany Announcements
Faron Pharmaceuticals Corrects 2025 Annual Report to Add Missing Auditor’s Report
1M ago
Faron Pharmaceuticals Publishes 2025 Annual Report Detailing Progress in Cancer Immunotherapies
PremiumCompany AnnouncementsFaron Pharmaceuticals Publishes 2025 Annual Report Detailing Progress in Cancer Immunotherapies
1M ago
Faron advances bexmarilimab program and shores up finances despite deeper losses in 2025
Premium
Company Announcements
Faron advances bexmarilimab program and shores up finances despite deeper losses in 2025
1M ago
Faron Shareholders Approve Major Rights Issue Authorization at Extraordinary Meeting
Premium
Company Announcements
Faron Shareholders Approve Major Rights Issue Authorization at Extraordinary Meeting
1M ago
De-Risked Development Path and Strong BEXMAB Efficacy Drive Reiterated Buy on Faron and £10 Target
PremiumRatings
De-Risked Development Path and Strong BEXMAB Efficacy Drive Reiterated Buy on Faron and £10 Target
2M ago
Faron plans €40m rights issue to fund bexmarilimab through key cancer trial milestones
PremiumCompany Announcements
Faron plans €40m rights issue to fund bexmarilimab through key cancer trial milestones
2M ago
Faron Registers 909,517 New Shares After Exercise of Special Rights
PremiumCompany Announcements
Faron Registers 909,517 New Shares After Exercise of Special Rights
2M ago
Faron Uses Share Settlement to Amortise Convertible Bonds, Adding 909,517 New Shares
PremiumCompany Announcements
Faron Uses Share Settlement to Amortise Convertible Bonds, Adding 909,517 New Shares
2M ago
Faron CFO Sells Entire Personal Stake in Biopharma Group
PremiumCompany AnnouncementsFaron CFO Sells Entire Personal Stake in Biopharma Group
3M ago
Faron Uses Treasury Shares to Settle Advanced Bond Amortisation and Adjusts Maturity Profile
Premium
Company Announcements
Faron Uses Treasury Shares to Settle Advanced Bond Amortisation and Adjusts Maturity Profile
3M ago
Faron Pharmaceuticals Revises Shareholders’ Nomination Board Composition
Premium
Company Announcements
Faron Pharmaceuticals Revises Shareholders’ Nomination Board Composition
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >